Skip to content

Physical Activity Component of the Greek Interventional Geriatric Study to Prevent Cognitive Impairment and Disability (GINGER)

Physical Activity Component of the Greek Interventional Geriatric Study to Prevent Cognitive Impairment and Disability (GINGER): Study Protocol and Feasibility of the Assessment

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06528379
Acronym
GINGER
Enrollment
200
Registered
2024-07-30
Start date
2024-05-20
Completion date
2026-09-30
Last updated
2024-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

People With Subjective Cognitive Impairement (SCI)

Brief summary

The Greek Interventional Geriatric Study to Prevent Cognitive Impairment and Disability (GINGER) is a six-month multimodal, multicenter study aimed at people with Subjective Cognitive Impairement (SCI). One of the GINGER's interventional components is the Physcial Activity (PA) component, coordinated by the University of Patras. This PA component's scope is to determine whether an enhanced individualized physical exercise intervention programme can improve cognitive changes, physical function, quality of life and wellbeing in people with subjective cognitive decline.

Interventions

BEHAVIORALPhysical Activity

The exercise programme is a 6-month progressive tailored-based exercise regime comprising * aerobic exercises (40-60%) * resistance exercises (20-40%) * balance with resistance exercises (20%) . This is peformed 3 times weekly, it is tailored to each individual but delivered in a small group-based manner. Two sessions are supervised by physiotherapist /exercise scientist and one session is unsupervised, home-based.

Sponsors

University Hospital of Patras
CollaboratorOTHER
University Hospital of Crete
CollaboratorOTHER
University of Patras
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

include people with: * Subjective Cognitive Decline confirmed from the Subjctive Cognitive Decline Questionnaire (SCD - Q score \>7) * Absence of objective cognitive imparement as confirmed from cognitive assessment tests (i.e. MoCA, Trail A & B, Stroop, RCFT, FAS. ) Exclusion Criteri include people with: * Mild Cognitive Impairement (MCI) or dementia * Chronic psychiatric or neurological disorders affecting cognition (i.e. bipolar disorder, schizophrenia, MS, TBI, Parkinson's disease etc.) * Unstable pathological diseases (i.e. uncontrolled hypothyrodism, athythmias, uncontrolled hypertension, high blood pressure at rest etc.) * Recent (\<6 month) surgery, which restrics active participation in exercise/physical activity * inadequate knowledge of Greek

Design outcomes

Primary

MeasureTime frameDescription
BalanceBaseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)The Greek version of the Mini-BESTest (Mini-Balance Evaluation Systems Test) is used to assess the balance of each participant comprising four primary assessment balance categories (anticipatory, reactive postural control, sensory orientation, dynamic gait). The Mini-BESTest focuses primarily on dynamic balance and contains 14 different balancing tasks, each scored from 0 (lowest level of function) to 2 (highest level of function). Thus, overall scores range from 0 (lowest level of function) to 28 (highest level of function) and subsequent subscales are scored as: Anticipatory tasts (0-6), Reactive Postural Control (0-6), Sensory Orientation (0-6) & Dynamic Gait (0-10). Mini-BESTest takes about 10-15 minutes to be administered.
Upper limb muscle strengthBaseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)The Hand Grip Strength test is an objective, established and standardised measure of upper limb muscle strength, comprising a standard electronic hand dynamometer (Jamar) for measuring muscle strength of the hand (measured in kgs).
Lower limb muscle strengthBaseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)The lower limbs strength is measured using the 30 seconds Sit-to-Stand test, which is an objective, established and standardised measure of lower limb muscle strength. Participants are seated in the front part of a standard chair with their hands crossed in front of their chest, and they are asked to stand up completely (full extension of their knees) and sit back down to the chair as many times as possible during 30 seconds (measuring the repetitions).
Aerobic capacityBaseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)The 2 Minute Walk Test is an established and objective test for measuring aerobic capacity. Participants are placed in a hallway of nine meters and are asked to cover as much ground as they can in two minutes (measured in meters).

Secondary

MeasureTime frameDescription
Physical FunctionBaseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)The International Physical Activity Questionnaire (IPAQ- 7) is used to evaluate physical function. IPAQ-7 is a 7-item questionnaire that calculates the physical activities taken place the last week (measured in METs).
Adherance to exerciseBaseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)The Exercise Adherance Rating Scale (EARS) is a validated and recently adapted into Greek outcome for measuring execise adhearance as well as the reasons of non-adhearing, comprising of 16 question items, exploring adhearance (6 question items) and reasons for adhearance/non-adhearance (10 items). Scores range from 0 (adherance) to 64 (non-adherance).
Fear of FallingBaseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)The Greek version of the Falls Self-efficacy International Scale (FES-I\_GREEK) is used to evaluate Fear of Falling. FES-I is a 16-item questionnaire with scores ranging from 16 to 64 points. Higher scores indicate higher fear and concern regarding falls.

Countries

Greece

Contacts

Primary ContactEvdokia Billis, PhD
billis@upatras.gr00306973047170
Backup ContactEftychia Nastou, MSC
nastou.e@upatras.gr00306948694966

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026